Kewaunee Scientific Corporation
KEQU
$37.50
$0.340.92%
NASDAQ
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.42% | -7.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.42% | -7.83% | |||
| Cost of Revenue | 0.40% | -5.53% | |||
| Gross Profit | -5.78% | -12.93% | |||
| SG&A Expenses | -3.15% | 3.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.46% | -3.43% | |||
| Operating Income | -14.62% | -43.41% | |||
| Income Before Tax | -11.91% | -45.17% | |||
| Income Tax Expenses | 20.24% | -65.44% | |||
| Earnings from Continuing Operations | -19.66% | -36.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -40.91% | 31.96% | |||
| Net Income | -20.95% | -36.23% | |||
| EBIT | -14.62% | -43.41% | |||
| EBITDA | -10.57% | -35.09% | |||
| EPS Basic | -21.37% | -36.16% | |||
| Normalized Basic EPS | -13.82% | -45.40% | |||
| EPS Diluted | -21.15% | -36.15% | |||
| Normalized Diluted EPS | -14.16% | -45.13% | |||
| Average Basic Shares Outstanding | 0.53% | -0.11% | |||
| Average Diluted Shares Outstanding | 0.91% | -0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||